553 related articles for article (PubMed ID: 28681958)
1. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway.
You Z; Timilshina M; Jeong BS; Chang JH
Eur J Immunol; 2017 Sep; 47(9):1488-1500. PubMed ID: 28681958
[TBL] [Abstract][Full Text] [Related]
2. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis.
Kang Y; Timilshina M; Nam TG; Jeong BS; Chang JH
Biol Res; 2017 Feb; 50(1):8. PubMed ID: 28241881
[TBL] [Abstract][Full Text] [Related]
3. BJ-3105, a 6-Alkoxypyridin-3-ol Analog, Impairs T Cell Differentiation and Prevents Experimental Autoimmune Encephalomyelitis Disease Progression.
Timilshina M; Kang Y; Dahal I; You Z; Nam TG; Kim KJ; Jeong BS; Chang JH
PLoS One; 2017; 12(1):e0168942. PubMed ID: 28095433
[TBL] [Abstract][Full Text] [Related]
4. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of suppressing the Jak/STAT pathway in multiple models of experimental autoimmune encephalomyelitis.
Liu Y; Holdbrooks AT; De Sarno P; Rowse AL; Yanagisawa LL; McFarland BC; Harrington LE; Raman C; Sabbaj S; Benveniste EN; Qin H
J Immunol; 2014 Jan; 192(1):59-72. PubMed ID: 24323580
[TBL] [Abstract][Full Text] [Related]
6. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Lee J; Choi J; Lee W; Ko K; Kim S
Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
8. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
9. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G
Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843
[TBL] [Abstract][Full Text] [Related]
10. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
11. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
13. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of Experimental autoimmune encephalomyelitis and DSS induced colitis by NTG-A-009 through the inhibition of Th1 and Th17 cells differentiation.
Acharya S; Timilshina M; Jiang L; Neupane S; Choi DY; Park SW; Lee SY; Jeong BS; Kim JA; Nam TG; Chang JH
Sci Rep; 2018 May; 8(1):7799. PubMed ID: 29773813
[TBL] [Abstract][Full Text] [Related]
15. CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Xia P; Gong X; Xiao L; Wang Y; Zhang T; Liao Q; Mo X; Qiu X; Huang J
Brain Behav Immun; 2018 Jul; 71():158-168. PubMed ID: 29548993
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis .
Zeitelhofer M; Adzemovic MZ; Gomez-Cabrero D; Bergman P; Hochmeister S; N'diaye M; Paulson A; Ruhrmann S; Almgren M; Tegnér JN; Ekström TJ; Guerreiro-Cacais AO; Jagodic M
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1678-E1687. PubMed ID: 28196884
[TBL] [Abstract][Full Text] [Related]
17. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
18. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
[TBL] [Abstract][Full Text] [Related]
19. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
[TBL] [Abstract][Full Text] [Related]
20. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
